Project Grant R44GM162107
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$676K
Federal Agency
National Institute of General Medical Sciences
Awardee
Ometa Labs LLC (LA5DWHNKT188)
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Carlsbad, CA 92010, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $330,076 Project Grant to Trestle Optics LLC under the Biomedical Research and Research Training (CFDA 93.859) federal grant program. The grant funding will support the development of a photothermal microscopy platform that can non-destructively profile metabolites in individual cells. The project aims to integrate photothermal microscopy with spatial light interference imaging to create a system capable of real-time,...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $350,000 to Sinopia Biosciences Inc. to develop computational methods for predicting the metabolomic profiles of unscreened chemical compounds. The goal is to enable more efficient metabolomics-based drug discovery by combining sparse experimental screening with computational inference. Key objectives include: 1) developing methods to...
The National Institute of General Medical Sciences (NIGMS) has awarded a $492,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Princeton University. The grant, which runs from Sep 1, 2024 to Aug 31, 2029, supports research aimed at accessing previously hidden sources of microbial natural products and investigating their structures, functions, therapeutic uses, and biosynthetic pathways. Key objectives include eliciting cryptic metabolites from...
The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), awarded a $780,000 Project Grant to Oregon Health & Science University (OHSU) effective September 1, 2024 through July 31, 2029. The grant supports the development of innovative proteomic tools to study transcription factor-coregulator interactions and their role in gene regulation, cellular differentiation, and disease progression. Key objectives include...
The National Institute of General Medical Sciences (NIGMS) awarded a $752,456 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Pittsburgh. The grant, effective September 1, 2024 through July 31, 2029, supports the development and application of innovative, user-friendly computational technologies for identifying new bioactive small molecules and improving their pharmacological properties. Key focus areas include creating a database of...
The National Institute of General Medical Sciences (NIGMS) awarded a $349,816 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Narwhal Bio, Inc. in San Diego, CA. The grant supports the development of a prototype instrument, software, and consumable for non-invasive live-cell identification, tagging, and downstream characterization. This novel platform aims to enable researchers to study clinically relevant cell-cell interactions that drive diseases like...
The National Institute of General Medical Sciences (NIGMS) awarded a $324,239 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Ora Biomedical, Inc., a biotechnology company in Seattle, WA. The purpose of this Phase I Small Business Innovation Research (SBIR) grant is to develop "ELEGANTRY", a software and hardware infrastructure to improve rigor and reproducibility in invertebrate research using the model organism Caenorhabditis elegans (C....
This $306,872 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of a commercial prototype for Fluid Discovery, Inc.'s "Universal Platform for Ultrahigh-Throughput Biocatalyst Evolution with Micro-Mass Spectrometry." This transformative screening platform combines scalable hardware, label-free mass spectrometry, and advanced computational techniques to...
The National Institute of General Medical Sciences (NIGMS) awarded a $635,246 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Georgia Tech Research Corporation. The grant, effective September 1, 2024 through June 30, 2028, supports the development of innovative bioorthogonal chemistry methods to facilitate interactions between biomolecules and small molecules for site-selective transformations in biological systems. The key objectives include: 1)...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of a novel computational platform for discovering non-ribosomal peptide natural products. The $781,502 award to Chemia Biosciences, Inc., a small disadvantaged business in Pittsburgh, PA, aims to create efficient and accurate methods for identifying new natural product small molecules from complex mass...